National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

recombinant human interleukin-2 (ree-KOM-bih-nunt HYOO-mun in-ter-LOO-kin...)

 A drug used to treat some types of cancer. It is a form of interleukin-2, a cytokine made by leukocytes (white blood cells), that is made in the laboratory. Recombinant human interleukin-2 increases the activity and growth of white blood cells called T lymphocytes and B lymphocytes. It is a type of biological response modifier. Also called aldesleukin and Proleukin.



Previous Definitions:receptor, recombinant, recombinant adenovirus-p53, recombinant fowlpox-CEA-MUC-1-TRICOM vaccine, recombinant fowlpox-TRICOM vaccine
Next Definitions:recombinant human methionyl stem cell factor, recombinant tissue plasminogen activator, recombinant vaccinia-CEA-MUC-1-TRICOM vaccine, recombinant vaccinia-TRICOM vaccine, reconstructive surgeon

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov